N-(2-(3-(4-(aminomethyl)phenyl)propylamino)ethyl)-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide

ID: ALA438621

PubChem CID: 10111743

Max Phase: Preclinical

Molecular Formula: C21H30N4O2S

Molecular Weight: 402.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NCc1ccc(CCCNCCNS(=O)(=O)c2ccc3c(c2)CNCC3)cc1

Standard InChI:  InChI=1S/C21H30N4O2S/c22-15-18-5-3-17(4-6-18)2-1-10-23-12-13-25-28(26,27)21-8-7-19-9-11-24-16-20(19)14-21/h3-8,14,23-25H,1-2,9-13,15-16,22H2

Standard InChI Key:  AXAWARWVQYJXEC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    6.7752   -0.4512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0675   -0.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0811    0.7964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4963   -0.0516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5060    0.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8022    1.1960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8120    2.0216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5331    2.4251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2407    1.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2271    1.1774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3464   -0.4288    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.9468    0.2885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7499   -1.1499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7933   -0.3241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0857   -0.7462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3645   -0.3427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3509    0.4790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0586    0.9049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7797    0.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4872    0.9235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2033    0.5239    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3430   -0.7688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0641   -0.3653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7717   -0.7874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -0.3877    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2004   -0.8098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9178   -0.4102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6253   -0.8323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  2 11  1  0
 11 12  2  0
 11 13  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 20 21  1  0
 16 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 11  1  0
M  END

Associated Targets(Human)

TPSAB1 Tclin Tryptase beta-1 (295 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.56Molecular Weight (Monoisotopic): 402.2089AlogP: 1.29#Rotatable Bonds: 10
Polar Surface Area: 96.25Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 10.37CX Basic pKa: 9.47CX LogP: 1.34CX LogD: -2.82
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.45Np Likeness Score: -0.80

References

1. Miyazaki Y, Kato Y, Manabe T, Shimada H, Mizuno M, Egusa T, Ohkouchi M, Shiromizu I, Matsusue T, Yamamoto I..  (2006)  Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.,  16  (11): [PMID:16540315] [10.1016/j.bmcl.2006.02.064]

Source